Basic Information | Post buying leads | Suppliers |
Name |
Oxprenolol hydrochloride |
EINECS | 229-260-5 |
CAS No. | 6452-73-9 | Density | N/A |
PSA | 50.72000 | LogP | 3.18200 |
Solubility | N/A | Melting Point |
91-93 °C |
Formula | C15H24ClNO3 | Boiling Point | 403.3 °C at 760 mmHg |
Molecular Weight | 301.813 | Flash Point | 197.7 °C |
Transport Information | N/A | Appearance | White Solid |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | Xi | |
Synonyms |
2-Propanol,1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-, hydrochloride (9CI);2-Propanol, 1-[o-(allyloxy)phenoxy]-3-(isopropylamino)-, hydrochloride(7CI,8CI);1-(2-Allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride;1-(2'-Allyloxyphenoxy)-2-hydroxy-3-isopropylaminopropane hydrochloride;1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propanol hydrochloride;1-(o-Allyloxyphenoxy)-3-isopropylamino-2-propranol-hydrochloride;1-Isopropyl-amino-2-hydroxy-3-(O-allyloxyphenoxy)propanehydrochloride;1-Isopropylamino-3-(o-allyloxyphenoxy)-2-propanol hydrochloride;Ba 39089;CIBA 39089Ba;Laracor;Oxiprenolol hydrochloride;Oxprenololhydrochloride;Paritane;Slow-Pren;Slow-Trasicor;Trasacor;Trasicor;Trasicor80;dl-Alprenolol hydrochloride;dl-Oxprenolol hydrochloride; |
The Oxprenolol hydrochloride, with the CAS registry number 6452-73-9, is also known as 2-Propanol,1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yloxy)phenoxy]-, hydrochloride (1:1). It belongs to the product categories of Amines; Aromatics; Intermediates & Fine Chemicals; Pharmaceuticals. Its EINECS number is 229-260-5. This chemical's molecular formula is C15H24ClNO3 and molecular weight is 301.81. What's more, its systematic name is 1-[2-(Allyloxy)phenoxy]-3-(isopropylamino)-2-propanol hydrochloride (1:1). Its classification codes are: (1)Drug / Therapeutic Agent (2)Human Data (3)Reproductive Effect (4)Vasodilator [coronary]. This chemical is a beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias and anxiety.
Physical properties of Oxprenolol hydrochloride are: (1)ACD/LogP: 2.291; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.73; (4)ACD/LogD (pH 7.4): 0.44; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 1.00; (8)ACD/KOC (pH 7.4): 5.94; (9)#H bond acceptors: 4; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 10; (12)Polar Surface Area: 30.93 Å2; (13)Flash Point: 197.7 °C; (14)Enthalpy of Vaporization: 69.02 kJ/mol; (15)Boiling Point: 403.3 °C at 760 mmHg; (16)Vapour Pressure: 3.15E-07 mmHg at 25°C.
Uses of Oxprenolol hydrochloride: it can be used to produce N-nitrosooxprenolol at the temperature of 50 °C. It will need reagents sodium nitrite, aq. HCl with the reaction time of 5 hours. The yield is about 85%.
When you are using this chemical, please be cautious about it as the following:
This chemical is irritating to eyes, respiratory system and skin. In case of contact with eyes, you should rinse immediately with plenty of water and seek medical advice. When using it, you need to wear suitable protective clothing, gloves and eye/face protection.
You can still convert the following datas into molecular structure:
(1)Canonical SMILES: CC(C)NCC(COC1=CC=CC=C1OCC=C)O.Cl
(2)InChI: InChI=1S/C15H23NO3.ClH/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3;/h4-8,12-13,16-17H,1,9-11H2,2-3H3;1H
(3)InChIKey: COAJXCLTPGGDAJ-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LD90 | oral | 200mg/kg (200mg/kg) | CARDIAC: PULSE RATE BEHAVIORAL: ATAXIA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968. |
dog | LD50 | intravenous | 15mg/kg (15mg/kg) | BEHAVIORAL: TREMOR CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP BEHAVIORAL: ATAXIA | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1890, 1970. |
dog | LDLo | oral | > 30mg/kg (30mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968. | |
dog | LDLo | subcutaneous | > 30mg/kg (30mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968. | |
mouse | LD50 | intraperitoneal | 170mg/kg (170mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: SLEEP | Polish Journal of Pharmacology and Pharmacy. Vol. 25, Pg. 151, 1973. |
mouse | LD50 | intravenous | 20mg/kg (20mg/kg) | AUTONOMIC NERVOUS SYSTEM: SYMPATHOMIMETIC | Arzneimittel-Forschung. Drug Research. Vol. 27, Pg. 1022, 1977. |
mouse | LD50 | oral | 520mg/kg (520mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3131, 1973. |
mouse | LD50 | subcutaneous | 245mg/kg (245mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: ATAXIA | Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968. |
rabbit | LDLo | intravenous | 20mg/kg (20mg/kg) | BEHAVIORAL: ATAXIA CARDIAC: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 20, Pg. 1890, 1970. |
rat | LD50 | intraperitoneal | 147mg/kg (147mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 3131, 1973. |
rat | LD50 | intravenous | 33mg/kg (33mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968. |
rat | LD50 | oral | 214mg/kg (214mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 35, Pg. 1236, 1985. | |
rat | LD50 | subcutaneous | 940mg/kg (940mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: ATAXIA BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 164, 1968. |
women | LDLo | oral | 90mg/kg (90mg/kg) | LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: GENERAL ANESTHETIC CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) | British Medical Journal. Vol. 1, Pg. 552, 1977. |
women | TDLo | oral | 160mg/kg (160mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: COMA VASCULAR: SHOCK | Human & Experimental Toxicology. Vol. 9, Pg. 101, 1990. |